Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2013
Total Assets: $47.51B
Liabilities Breakdown FY2013
Total Liabilities: $24.87B
Asset Breakdown
Total Assets: $47.51B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.04B | 2.2% |
| Accounts Receivable | $5.34B | 11.2% |
| Inventory | $5.05B | 10.6% |
| Property, Plant & Equipment | $6.64B | 14.0% |
| Goodwill | $18.98B | 40.0% |
| Intangible Assets | $6.48B | 13.6% |
| Other Assets | $3.99B | 8.4% |
Liabilities Breakdown
Total Liabilities: $24.87B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $11.20B | 45.0% |
| Other Liabilities | $13.67B | 55.0% |